Through a new A.I. project, Microsoft hopes to tackle that by making diagnosing nearly any disease as simple as a single blood test.
“My Greatest Achievement Has Been Overcoming My Own Shyness to Advocate My Disabled Child” – Judith Sheppard
Judith Sheppard is the parent of a 22-year-old young man with FOXG1 Syndrome. We’ve had a chat with her before her talk “Finding the Needle in the Haystack” at the Festival of Genomics in London 2018.
The FDA have approved the first drug to treat women with advanced breast cancer caused by the same flawed gene that Angelina Jolie made famous.
As a part of an effort to understand what health issues might be particular to people in the Nevada region, The Healthy Nevada Project is planning to sequence the DNA of 40,000 Nevadans.
How consumer genetic testing companies actually use your DNA is often less than clear and made more opaque through legal jargon and vagaries.
EncrpGen have come forward with a solution that allows you to take control of your own genetic makeup, after 23andMe faces backlash.
In a new study, melanoma patients who received immunotherapy while taking a specific type of beta blocker lived longer than patients who received immunotherapy alone, researchers report.
It has been widely reported that bacteria will evolve to render antibiotics mostly ineffective by mid-century—and current strategies to make up for the projected shortfalls haven’t worked.
When a hepatitis C treatment called Harvoni was released in 2014, Dr. Ronald Cirillo knew it was a big deal.
Pfizer has announced that it will be abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease.